Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 33 (RPL17P33)

Target: RPL17P33
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L17 pseudogene 33 (RPL17P33) is a processed pseudogene related to the functional ribosomal protein L17 (RPL17) gene. Pseudogenes like RPL17P33 arise from the reverse transcription of functional genes but accumulate mutations that render them nonfunctional: they do not produce protein and have no known biological or therapeutic roles. The gene is annotated in databases such as Ensembl (ENSG00000243844) as lacking protein-coding capacity and is not targeted by approved drugs or used as a clinical biomarker.

Other names: RPL17_19_888RPL17P33

Mechanism of action

None (no drugs act on this pseudogene)

Biological functions

None (does not code for a functional protein and has no established biological function)

Disease associations

None directly; RPL17 pseudogenes are not implicated in known diseases. However, processed pseudogenes sometimes serve as evolutionary markers or have minor regulatory roles

Safety considerations

None (not a target for drug development, so no safety concerns)

Interacting drugs

None (not a functional protein, so no drugs interact directly with this pseudogene)

Biomarkers

None (not used as a biomarker in clinical or research settings)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 33 (RPL17P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 33 (RPL17P33).

Explore the full profile